Nexelis, A Q² Solutions Company
Pharmaceuticals, 645 Elliott Ave W, Laval, Washington, 98119, United States, 51-200 Employees
Phone Number: 14*********
Who is NEXELIS, A Q² SOLUTIONS COMPANY
With unrivaled expertise in immunology, 5 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lea...
Read More
-
Headquarters: 645 Elliott Ave W, Laval, Washington, 98119, United States
-
Date Founded: 1989
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8071
|
NAICS Code: 621511 |
Show More
Does something look wrong? Fix it. | View contact records from NEXELIS, A Q² SOLUTIONS COMPANY
Nexelis, a Q² Solutions Company Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nexelis, a Q² Solutions Company
Answer: Nexelis, a Q² Solutions Company's headquarters are located at 645 Elliott Ave W, Laval, Washington, 98119, United States
Answer: Nexelis, a Q² Solutions Company's phone number is 14*********
Answer: Nexelis, a Q² Solutions Company's official website is https://pacbio.com
Answer: Nexelis, a Q² Solutions Company's revenue is $50 Million to $100 Million
Answer: Nexelis, a Q² Solutions Company's SIC: 8071
Answer: Nexelis, a Q² Solutions Company's NAICS: 621511
Answer: Nexelis, a Q² Solutions Company has 51-200 employees
Answer: Nexelis, a Q² Solutions Company is in Pharmaceuticals
Answer: Nexelis, a Q² Solutions Company contact info: Phone number: 14********* Website: https://pacbio.com
Answer: With unrivaled expertise in immunology, 5 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lead selection to the late clinical stage, Nexelis, a Q2 Solutions Company, is a leading provider of assay development and advanced laboratory testing services in the infectious, metabolic and oncologic fields. Our versatile team of scientists, working with state of the art technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 350 new molecular entities, including blockbuster vaccines and biologics, anti-viral drugs, immunotherapy, gene and cell therapy products.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month